Multi-drug resistant bacteria infection and clinical outcome of diabetic foot: An update
10.3760/cma.j.cn311282-20210824-00544
- VernacularTitle:糖尿病足多重耐药菌感染与临床结局的研究进展
- Author:
Yi ZOU
1
;
Xuelei JI
;
Zhichu REN
;
Wenli XIA
Author Information
1. 皖南医学院研究生学院，芜湖 241000
- Keywords:
Diabetic foot;
Multi-drug resistant bacteria;
Risk factors;
Clinical outcome
- From:
Chinese Journal of Endocrinology and Metabolism
2022;38(4):345-348
- CountryChina
- Language:Chinese
-
Abstract:
With multi-drug-resistant bacteria being more prevalent over years, diabetic foot complicated with multi-drug-resistant bacteria infection emerges as a significant challenge for clinicians and patients. Diabetic foot is predisposed to multi-drug resistant bacterial infection. Growing body of evidence shows that ulcer type, ulcer grade, ulcer area, history of antibiotics treatment, previous hospitalization history, osteomyelitis, and proliferative retinopathy are risk factors. Among multi-drug-resistant bacteria, methicillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing bacteria are the most common strains. Infection with multiple drug-resistant bacteria contributes to the amputation rate and mortality in patients with diabetic foot ulcers. The aim of this review is to give an update on multi-drug resistant bacteria infection and clinical outcome of diabetic foot, with a goal to improve clinical awareness and management.
